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Abstract
The scale-up of malaria control efforts in recent years, coupled with major investments in malaria research, has
produced impressive public health impact in a number of countries and has led to the development of new tools
and strategies aimed at further consolidating malaria control goals. As a result, there is a growing need for the
malaria policy setting process to rapidly review increasing amounts of evidence.
The World Health Organization Global Malaria Programme, in keeping with its mandate to set evidence-informed
policies for malaria control, has convened the Malaria Policy Advisory Committee as a mechanism to increase the
timeliness, transparency, independence and relevance of its recommendations to World Health Organization
member states in relation to malaria control and elimination.
The Malaria Policy Advisory Committee, composed of 15 world-renowned malaria experts, will meet in full twice a
year, with the inaugural meeting scheduled for 31 January to 2 February 2012 in Geneva. Policy recommendations,
and the evidence to support them, will be published within two months of every meeting as part of an open
access Malaria Journal thematic series. This article is a prelude to that series and provides the global malaria
community with the background and overview of the Committee and its terms of reference.
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Background
The World Health Organization Global Malaria Pro-
gramme (WHO-GMP) has four essential roles [1] (i) to set,
communicate, and promote the adoption of evidence-based
norms, standards, policies, and guidelines; (ii) to keep inde-
pendent score of global progress; (iii) to develop approaches
for capacity building, systems strengthening and surveil-
lance; and (iv) to identify threats to malaria control and
elimination, as well as new opportunities for action.
Last year, WHO-GMP embarked on a major review and
re-design of its policy setting process in order to be more
responsive to the rapidly evolving malaria landscape. As
highlighted in the World Malaria Report 2011 published
last month, the world is witnessing impressive progress in
the development and uptake of malaria control tools,
resulting in significant reductions of malaria-related mor-
bidity and mortality in many countries [2]. At the same
time, there is increasing pressure on the malaria policy
setting process to keep pace with the evidence being gen-
erated both through research efforts and the massive
implementation of malaria control tools. A stronger and
more agile policy setting approach is increasingly impor-
tant and necessary in the face of a projected shortfall in
funding and growing resistance of Plasmodium falciparum
to anti-malarial drugs and of anopheline mosquitoes to
insecticides [2-4]. The global malaria community must
m a k et h em o s te f f e c t i v eu s eo ft h et o o l si th a si no r d e r
to meet international targets for malaria control set for
2015 [2].
A small group of independent malaria experts was con-
vened in March 2011 in Geneva to review previous and
existing malaria policy processes and successful policy-set-
ting models from other WHO departments. They pro-
posed a framework for a new malaria policy committee -
strongly modelled on the Strategic Advisory Group of
Experts (SAGE), which sets global policy for immuniza-
tions - to address the shortcomings of previous policy pro-
cesses. During April and May 2011, feedback on the draft
terms of reference was sought, received, and incorporated
from 50 external stakeholders.
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WHO Director General in August, an open call for
nominations was held in September 2011. From the 100
applications received, an independent nomination panel
with representation from key partner organizations
selected 15 members, who were appointed in November
2011 by the WHO Director General [5].
The inaugural meeting of the Malaria Policy Advisory
Committee (MPAC) will take place in Geneva from 31
January to 2 February 2012 in open session [6]. The com-
plete terms of reference for the Committee, outlined in
this article, are publicly available online for reference [7].
Aims and functions of the Malaria Policy Advisory
Committee
The mandate of MPAC is to provide independent strategic
advice and technical input for the development of WHO
policy recommendations on all aspects of malaria control
and elimination as part of a transparent, responsive and
credible policy setting process.
The MPAC advises the WHO Director-General speci-
fically on:
1. appropriate malaria policies and standards based on
programmatic experience by WHO member states and
malaria control partners as well as reviews of the best
available evidence;
2. engagement of WHO-GMP in malaria-related
initiatives;
3. major issues and challenges to achieving global
malaria goals;
4. the identification of priority research and control
activities to address identified challenges.
Roles and responsibilities of MPAC members
The MPAC’s 15 members serve in a personal capacity
and represent a broad range of disciplines, expertise, and
experience encompassing many aspects of malaria con-
trol and elimination. Members of MPAC, including the
Chair, have been appointed to serve for an initial term of
three years. Each term may only be renewed once, for a
period of up to an additional three years.
The MPAC has no executive or regulatory function.
I t sr o l ei ss o l e l yn o r m a t i v e ;i tp r o v i d e sa d v i c ea n d
recommendations to the WHO Director General,
including response to urgent issues as needed. Members
of MPAC play a critical role in ensuring the reputation
of WHO in providing high quality, well considered, evi-
dence-informed advice and recommendations on
malaria control and elimination. A register of members’
declaration of interests is maintained by WHO and will
be made available on the WHO-GMP website.
Meetings and operational procedures
The MPAC will meet bi-annually for three days, with
dates generally set at least six months in advance. The
frequency and duration of meetings will be adjusted as
necessary. MPAC recommendations will be taken by
consensus. In the exceptional situation that consensus
on a particular issue cannot be reached, the Chair shall
report the majority and minority view.
Representatives of the Roll Back Malaria Partnership
Secretariat, the Global Fund to fight AIDS, Tuberculosis
and Malaria Secretariat, the United Nations Children’s
Fund and the Office of the United Nations Special Envoy
for Malaria have been invited to participate as standing
observers in MPAC meetings and deliberations. Relevant
staff from WHO Headquarters and Regional Offices will
attend as members of the Secretariat. In addition, three
rotating National Malaria Control Programme managers
from around the world will be invited as resource persons
to observe and participate in the meeting.
The MPAC meetings are open to other observers,
including representatives from WHO regional technical
advisory groups, non-governmental organizations, techni-
cal agencies, academic institutions, and donor organiza-
tions. Additional experts and technical resource persons
may also be invited to meetings to contribute to specific
agenda items. Observers will not take the floor unless
requested to do so by the Chair and will not participate in
the formulation of MPAC recommendations.
The MPAC will work with WHO-GMP to develop its
priorities of work and meeting agendas, with input from
malaria endemic countries. In time, a wider group will be
invited to contribute on agenda items in advance of each
meeting via open consultation on the WHO-GMP
website.
The MPAC will be kept informed by WHO-GMP and
partner agencies of progress in the implementation of
strategies and the attainment of objectives at both a
country and regional level.
Evidence review mechanism
Time-limited and specific Evidence Review Groups
(ERGs) will be established to review and provide evi-
dence-based information and options for recommenda-
tions. These options will be discussed by the full MPAC
in sessions open to representatives of stakeholders inter-
ested in malaria.
Selected current Technical Expert Groups (TEGs), e.g.
the TEG on malaria chemotherapy, will continue to
function but will fall under the umbrella of MPAC
together with the shorter-term ERGs. The MPAC,
together with the WHO-GMP Director, will review the
need for existing TEGs, and the creation of new ones,
on a regular basis.
A transparent and timely policy setting process
In order to seek broader input and allow for the exchange
of information and views, and to ensure transparency and
inclusivity, the majority of discussions will occur in open
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ment of recommendations by the MPAC will take place in
a closed session in order to protect the integrity and inde-
pendence of the committee from pressure and undue
influence. Transparency is still ensured however as min-
utes will be made available on the WHO-GMP website
following each meeting, together with the approved
MPAC recommendations which will be published within
two months of every meeting in the Malaria Journal.
Approved meeting agendas, minutes, and recommenda-
tions will be archived and will continue to remain publicly
available and easily accessible on the WHO-GMP website.
T h i sa r t i c l ei st h ef i r s ti nw h a tw i l lb eat h e m a t i cs e r -
ies of policy recommendations to be published in the
Malaria Journal following every MPAC meeting.
Conditional policy recommendations
In the absence of a robust evidence base, temporary condi-
tional recommendations, clearly identified as such and
based on a combination of the best available evidence and
expert opinion, may be issued to provide guidance for
regions and countries in the interim period. Conditional
recommendations will be reviewed regularly at MPAC
meetings in case adjustments need to be made based on
newly available evidence.
Discussion
The call to strengthen the policy setting process for
malaria control and elimination so that it is more respon-
sive to the rapidly evolving malaria landscape has been
heard. In critically reviewing its policy setting process and
implementing changes to increase the timeliness and
transparency of its policy recommendations, WHO-GMP
is highlighting both its willingness to engage with key part-
ners and its commitment to assist WHO member states in
meeting their goals for malaria control and elimination.
WHO-GMP has reached this stage of strengthening the
policy setting process for malaria control and elimination
through the support of the global malaria community.
Convening the MPAC is just the first step in making the
policy setting process truly timely and transparent.
WHO-GMP and MPAC will need to continue to
engage with the global malaria community in order to
successfully fulfil their roles and functions. Further
strengthening the policy setting process for malaria con-
trol and elimination will involve drawing on the
strengths of the global malaria community and the tools
in their arsenal. This will include requesting expertise
and experience for ERGs and TEGs in order to inform
malaria policy recommendations.
Conclusion
The malaria landscape will continue to evolve. However,
change, if anticipated and effectively responded to, can
bring about positive transformation. WHO-GMP, MPAC,
and the global malaria community as a whole, together
have an unprecedented window of opportunity to set poli-
cies and programmes in place that will enable them to
achieve the ambitious global goals that have been set for
malaria.
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